about
Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients seraThe Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi InfectionStem Cell-Based Therapies in Chagasic CardiomyopathyCharacterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.Small ncRNA transcriptome analysis from kinetoplast mitochondria of Leishmania tarentolae.New drugs for neglected infectious diseases: Chagas' disease.Regulatory T cells phenotype in different clinical forms of Chagas' diseaseShort-term follow-up of chagasic patients after benzonidazole treatment using multiple serological markers.Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease.Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial.Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review.IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes.Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).Clinical aspects of Chagas disease and implications for novel therapies.Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in miceCharacterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.Mechanism of Trypanosoma cruzi Placenta Invasion and Infection: The Use of Human Chorionic Villi Explants.Current concepts in immunoregulation and pathology of human Chagas disease.Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?Diagnosis and management of Chagas disease and cardiomyopathy.Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.Pathogenesis of Chagas disease: time to move on.Electrocardiographic findings in acutely and chronically T. cruzi-infected mice treated by a phenyl-substituted analogue of furamidine DB569.Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.Characterization of CD4⁺ cytotoxic lymphocytes and apoptosis markers induced by Trypanossoma cruzi infection.Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease.The relationship between heart rate variability and serum cytokines in chronic chagasic patients with persistent parasitemia.Preinfection aerobic treadmill training improves resistance against Trypanosoma cruzi infection in mice.Immunological imbalance between IFN-gamma and IL-10 levels in the sera of patients with the cardiac form of Chagas disease.
P2860
Q21198946-0D250170-4D2B-4255-960F-E719829F8050Q26829884-841D7C23-92D4-4B6C-809B-582BBA4A49AFQ26852985-84DFD2A9-CC6F-49AE-93B8-CB30BD4F94DAQ30918385-C8ABFA77-4300-427F-8657-7C7D4A4A19D1Q33272720-84227713-F55D-44E3-A5D8-5E3F1C95420CQ33870393-960AF331-1413-4B0A-9D2F-A0FB1D7D1B79Q33927456-4DA8A9AC-184C-4D55-A648-22E112E57420Q33975717-431E517C-4EC5-4721-A1DD-32F95DB7EE17Q34177376-22C3E301-6546-4B02-8B90-621DA1FF7996Q34194593-850490DC-431B-41E8-8785-0D5A483511F9Q34478887-3B16D24B-FF04-483E-8906-2AE8EC527CD3Q34531351-C83C3BEF-4AF6-40EF-859B-3E82784F7BC1Q34992879-5555CBC6-EA27-4279-B768-0D6C919F5AFFQ35048439-242F4901-2C21-4B34-955A-70D69BB747DCQ35114499-7413504B-30B1-4968-BEC8-2757232229FAQ35676177-43C7E5F7-F978-48CE-9981-1227ECAF20A1Q35689168-3A9EB1B3-8156-474A-B395-E6BB1975F63CQ35739066-AF8BC511-62BE-4855-8570-86A3031424BEQ36014601-E62CD3C7-969B-437E-9ED3-DE18D3D1FA1EQ37151780-AC579C41-A4E4-4C7F-AFB5-80CBEB9A7CA6Q37597066-B3F48C58-3216-4144-9461-4E6469D4C97AQ38030830-0245BE28-A3CD-4B1D-959A-654834B2A19EQ39329438-0E7EDB27-580E-43F2-9583-7359AD1A20ECQ40291208-7F12E263-2C86-4B53-9D3D-D2EB05DD6228Q42067939-16F420C1-582E-4508-8E4E-C5A5FF191B7AQ42118281-0983821C-6226-4CB0-8007-AE2D4269550EQ43659552-A7457B1F-7C37-4EBE-BB27-A5CA321045C2Q46187530-1F6EAEBF-38A0-4CD4-9069-8D6A92D66EA2Q51608812-D69E9F89-B339-45B1-89E5-14D536E39006Q51613708-7E0399D4-68D3-420E-ABC0-73FB67FDA6D3Q51775764-35D6D705-F573-4BEA-8E12-C1586BB097DD
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The clinical immunology of human Chagas disease.
@ast
The clinical immunology of human Chagas disease.
@en
type
label
The clinical immunology of human Chagas disease.
@ast
The clinical immunology of human Chagas disease.
@en
prefLabel
The clinical immunology of human Chagas disease.
@ast
The clinical immunology of human Chagas disease.
@en
P356
P1476
The clinical immunology of human Chagas disease.
@en
P2093
Manoel Otávio C Rocha
Walderez O Dutra
P304
P356
10.1016/J.PT.2005.09.007
P577
2005-10-19T00:00:00Z